These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19547978)

  • 1. Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
    Reiss AB; Anwar K; Merrill JT; Chan ES; Awadallah NW; Cronstein BN; Michael Belmont H; Belilos E; Rosenblum G; Belostocki K; Bonetti L; Hasneen K; Carsons SE
    Rheumatol Int; 2010 Mar; 30(5):591-8. PubMed ID: 19547978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis.
    Reiss AB; Wan DW; Anwar K; Merrill JT; Wirkowski PA; Shah N; Cronstein BN; Chan ES; Carsons SE
    Exp Biol Med (Maywood); 2009 Mar; 234(3):354-60. PubMed ID: 19144874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages.
    Reiss AB; Patel CA; Rahman MM; Chan ES; Hasneen K; Montesinos MC; Trachman JD; Cronstein BN
    Med Sci Monit; 2004 Nov; 10(11):BR420-5. PubMed ID: 15507847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages.
    Reiss AB; Carsons SE; Anwar K; Rao S; Edelman SD; Zhang H; Fernandez P; Cronstein BN; Chan ES
    Arthritis Rheum; 2008 Dec; 58(12):3675-83. PubMed ID: 19035488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.
    Reiss AB; Arain HA; Kasselman LJ; Renna HA; Zhen J; Voloshyna I; DeLeon J; Carsons SE; Petri M
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438615
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages.
    Reiss AB; Awadallah NW; Malhotra S; Montesinos MC; Chan ES; Javitt NB; Cronstein BN
    J Lipid Res; 2001 Nov; 42(11):1913-22. PubMed ID: 11714861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
    Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
    Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.
    Voloshyna I; Modayil S; Littlefield MJ; Belilos E; Belostocki K; Bonetti L; Rosenblum G; Carsons SE; Reiss AB
    Exp Biol Med (Maywood); 2013 Oct; 238(10):1192-7. PubMed ID: 24000379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus.
    Chan HC; Chan HC; Liang CJ; Lee HC; Su H; Lee AS; Shiea J; Tsai WC; Ou TT; Wu CC; Chu CS; Dixon RA; Ke LY; Yen JH; Chen CH
    Arthritis Rheumatol; 2020 Jun; 72(6):972-984. PubMed ID: 31994323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein functionality in systemic lupus erythematosus.
    Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
    Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
    McMahon M; Hahn BH
    Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages.
    Reiss AB; Rahman MM; Chan ES; Montesinos MC; Awadallah NW; Cronstein BN
    J Leukoc Biol; 2004 Sep; 76(3):727-34. PubMed ID: 15197231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
    Voloshyna I; Kasselman LJ; Carsons SE; Littlefield MJ; Gomolin IH; De Leon J; Reiss AB
    J Investig Med; 2017 Mar; 65(3):694-704. PubMed ID: 27940550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB; Giles IP; Rahman A
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia in systemic lupus erythematosus.
    Szabó MZ; Szodoray P; Kiss E
    Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.
    Voloshyna I; Teboul I; Littlefield MJ; Siegart NM; Turi GK; Fazzari MJ; Carsons SE; DeLeon J; Reiss AB
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1611-9. PubMed ID: 27190277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.
    Braun Na; Wade NS; Wakeland EK; Major AS
    Lupus; 2008 Dec; 17(12):1070-8. PubMed ID: 19029274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
    Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
    Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of autoantibodies to ATP-binding cassette transporter A1 and its role in the pathogenesis of atherosclerosis in patients with systemic lupus erythematosus.
    Zeng T; Li SJ; Ao W; Zheng H; Wu FX; Chen Y; Yang CD
    Clin Biochem; 2012 Nov; 45(16-17):1342-6. PubMed ID: 22709931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.